Browsing by Author Satti, I

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
2017Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trialsSmith, SG; Harris, SA; Satti, I; Bryan, D; Walker, KB; Dockrell, HM; McShane, H; Ho, MM
27-Sep-2018Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infectionO’Shea, MK; Tanner, R; Müller, J; Harris, SA; Wright, D; Stockdale, L; Stylianou, E; Satti, I; Smith, SG; Dunbar, J; Fletcher, TE; Dedicoat, M; Cunningham, AF; McShane, H
5-Jan-2022Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG VaccinationBitencourt, J; Peralta-Álvarez, MP; Wilkie, M; Jacobs, A; Wright, D; Salman Almujri, S; Li, S; Harris, SA; Smith, SG; Elias, SC; White, AD; Satti, I; Sharpe, SS; O’Shea, MK; McShane, H; Tanner, R
2011A phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsMinassian, AM; Rowland, R; Beveridge, NE; Poulton, ID; Satti, I; Harris, S; Poyntz, H; Hamill, M; Griffiths, K; Sander, CR; Ambrozak, DR; Price, DA; Hill, BJ; Casazza, JP; Douek, DC; Koup, RA; Roederer, M; Winston, A; Ross, J; Sherrard, J; Rooney, G; Williams, N; Lawrie, AM; Fletcher, HA; Pathan, AA; McShane, H
2012A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicityRowland, R; Brittain, N; Poulton, ID; Minassian, AM; Sander, C; Porter, DW; Satti, I; Pathan, AA; Lawrie, AM; McShane, H; Williams, N